Results 101 to 110 of about 16,645 (269)

The Role of Genetics in Stroke Risk and Outcome: A Review of Current Evidence

Brain and Behavior, Volume 15, Issue 10, October 2025.
This study delineates the multiple pathways leading to stroke, encompassing genetic risk factors such as lipid/cholesterol metabolism, blood pressure regulation genes, and endothelial dysfunction. The report includes genetic pathways such as Val66Met polymorphism, prothrombin G20210A, interleukin‐6 and tumor necrosis factor gene variant, along with ...
Mega Obukohwo Oyovwi, Benneth Ben‐Azu, Ejayeta Jeroh, Faith B. Friday   +3 more
wiley   +1 more source

Risk factors of ischemic stroke and subsequent outcome in hemodialysis patients [PDF]

, 2015
Background and purpose: End stage renal disease (ESRD) requiring hemodialysis (HD) carries up to a 10-fold greater risk of stroke than normal renal function. Knowledge concerning risk factors and management strategies derived from the general population
Dawson, Jesse, Findlay, Mark D., Fulton, Rachael L., Geddes, Colin C., Jardine, Alan G., Mark, Patrick B., Patel, Rajan K., Solbu, Marit D., Stevens, Kathryn K., Thomson, Peter C.   +9 more
core   +1 more source

Edoxaban Versus Warfarin

Journal of the American College of Cardiology, 2017
Steffel et al. [(1)][1] found that elderly atrial fibrillation patients receiving anticoagulation therapy and at increased fall risk had increased rate of bone fractures due to falling, which was similar between the use of 2 anticoagulants, edoxaban and warfarin (adjusted hazard ratio: 0.94; 95%
Hiromi Oda, Toshihiro Sugiyama
openaire   +3 more sources

Unintended Electrical Isolation of the Left Atrial Appendage due to Anatomical Misidentification During Pulsed‐Field Ablation: A Case Report

Journal of Arrhythmia, Volume 41, Issue 5, October 2025.
During pulsed‐field ablation, unintended left atrial appendage isolation occurred due to anatomical misidentification with the left superior pulmonary vein. Left atrial appendage potentials improved after 1 month. This case highlights procedural tips to avoid this complication and emphasizes post‐procedural monitoring and management strategies.
Naoki Matsumoto, Kenji Shimeno, Masanori Matsuo, Yukio Abe, Daiju Fukuda   +4 more
wiley   +1 more source

Surgical embolectomy for acute massive pulmonary embolism: state of the art [PDF]

, 2018
Massive pulmonary embolism (PE) is a severe condition that can potentially lead to death caused by right ventricular (RV) failure and the consequent cardiogenic shock.
De Bellis, Antonio, D’Abramo, Mizar, Frati, Giacomo, Greco, Ernesto, Iaccarino, Alessandra, Iovine, Elio, Saade, Wael, Schirone, Leonardo, Sciarretta, Sebastiano   +8 more
core   +1 more source

Edoxaban in Asian Patients With Atrial Fibrillation

Journal of the American College of Cardiology, 2018
It is unclear whether edoxaban shows better risk reduction of ischemic stroke, bleeding, and all-cause mortality than warfarin in Asian patients with nonvalvular atrial fibrillation (AF).This study compared the effectiveness and safety of edoxaban with those of warfarin in a Korean population with AF.Using the Korean National Health Insurance Service ...
Lee, So-Ryoung, Choi, Eue-Keun, Han, Kyung-Do, Jung, Jin-Hyung, Oh, Seil, Lip, Gregory Y H   +5 more
openaire   +4 more sources

Restarting Oral Anticoagulation in Patients With Atrial Fibrillation After Admission for a Gastrointestinal Bleeding Event: Effectiveness and Safety of Direct Oral Anticoagulants Compared to Warfarin

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 45, Issue 10, Page 638-653, October 2025.
ABSTRACT Background There are sparse data to guide resumption of direct oral anticoagulants (DOACs) versus warfarin in patients with atrial fibrillation (AF) who survive a major gastrointestinal bleeding (GIB) event. Objective To compare the risk–benefit profile of restarting DOACs versus warfarin among patients with AF following hospitalization for ...
Oluwadolapo D. Lawal, Herbert D. Aronow, Fisayomi Shobayo, Yichi Zhang, Anne L. Hume, Tracey H. Taveira, Kelly L. Matson, Justin Gold, Xuerong Wen   +8 more
wiley   +1 more source

Viewpoint Stroke prevention in recent guidelines for the management of patients with atrial fibrillation: An appraisal. [PDF]

, 2017
Formal guidelines play an important role in disseminating the best available evidence knowledge and are expected to provide simple and practical recommendations for the most optimal management of patients with various conditions.
Camm, AJ, Chiang, C-E, Lip, GYH, Lundqvist, CB, Potpara, TS   +4 more
core   +3 more sources

Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundElderly patients with atrial fibrillation are at higher risk of both ischemic and bleeding events compared to younger patients. In a prespecified analysis from the ENGAGE AF‐TIMI 48 trial, we evaluate clinical outcomes with edoxaban versus ...
Eri Toda Kato, Robert P. Giugliano, Christian T. Ruff, Yukihiro Koretsune, Takeshi Yamashita, Robert Gabor Kiss, Francesco Nordio, Sabina A. Murphy, Tetsuya Kimura, James Jin, Hans Lanz, Michele Mercuri, Eugene Braunwald, Elliott M. Antman   +13 more
doaj   +1 more source

Anticoagulated patient’s perception of their illness, their beliefs about the anticoagulant therapy prescribed and the relationship with adherence: impact of novel oral anticoagulant therapy – study protocol for The Switching Study: a prospective cohort study [PDF]

, 2016
Background Anticoagulant therapy is prescribed for millions of patients worldwide for the prevention and treatment of both arterial and venous thrombosis. Historically, only vitamin K antagonists have been available for clinicians to prescribe.
Alison Brown, Bipin Vadher, Jignesh P. Patel, John K. Abdou, Lara N. Roberts, Lynda Bonner, Raj K. Patel, Roopen Arya, Vivian Auyeung   +8 more
core   +1 more source